Patent: 4,372,747
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 4,372,747
Title: | Glycohemoglobin determination |
Abstract: | A method of measuring glycosylated hemoglobin featuring, in one aspect, providing a sample containing hemoglobin, including an unknown amount of glycosylated hemoglobin, contacting the sample with an oxidizing agent to generate formaldehyde, and measuring the formaldehyde as a measure of glycosylated hemoglobin, the measuring being carried out by reacting the formaldehyde with a water-soluble amine or an ammonium salt and a .beta.-diketone to generate a fluorescent compound whose fluorescence is measured as a measure of glycosylated hemoglobin. |
Inventor(s): | Gabbay; Kenneth (Chestnut Hill, MA), Gallop; Paul M. (Chestnut, MA) |
Assignee: | Children\'s Hospital Medical Center (Boston, MA) |
Application Number: | 06/288,777 |
Patent Claims: | see list of patent claims |
Details for Patent 4,372,747
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | PANHEMATIN | hemin for injection | For Injection | 101246 | 07/20/1983 | See Plans and Pricing | 2040-01-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |